The rapid rise in antibiotic-resistant pathogens is one of the grand challenges in life sciences. This project aims to harness cutting-edge microbiological and sequencing technologies and bioinformatics to 1) revolutionize infection diagnostics enabling early recognition and personalized treatment of hospital acquired infections and 2) enable epidemiological inference and understand associations between microbiome, drug responses, and treatment outcomes. Furthermore, the project will develop quantitative strategies to combat antimicrobial resistance (AMR) in originating hotspots including food production settings and sewage treatment plants.
Number of participating PI’s at start: 16
Partner organisations: Aalto University, University of Jyväskylä, University of Turku, Finnish Food Safety Authority Evira
Follow us on Twitter @HILIFE_AMR